DE69937735D1 - Phagen-display-selektionssystem für korrekt gefaltete proteine - Google Patents

Phagen-display-selektionssystem für korrekt gefaltete proteine

Info

Publication number
DE69937735D1
DE69937735D1 DE69937735T DE69937735T DE69937735D1 DE 69937735 D1 DE69937735 D1 DE 69937735D1 DE 69937735 T DE69937735 T DE 69937735T DE 69937735 T DE69937735 T DE 69937735T DE 69937735 D1 DE69937735 D1 DE 69937735D1
Authority
DE
Germany
Prior art keywords
virus
polypeptide
phag
selection system
display selection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69937735T
Other languages
English (en)
Other versions
DE69937735T2 (de
Inventor
Lutz Riechmann
Peter Kristensen
Jean-Luc Jestin
Gregory Paul Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Domantis Ltd
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810223.9A external-priority patent/GB9810223D0/en
Priority claimed from GBGB9810228.8A external-priority patent/GB9810228D0/en
Application filed by Domantis Ltd filed Critical Domantis Ltd
Publication of DE69937735D1 publication Critical patent/DE69937735D1/de
Application granted granted Critical
Publication of DE69937735T2 publication Critical patent/DE69937735T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Saccharide Compounds (AREA)
  • Vehicle Body Suspensions (AREA)
  • Circuits Of Receivers In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Air Bags (AREA)
DE69937735T 1998-05-13 1999-05-13 Phagen-display-selektionssystem für korrekt gefaltete proteine Expired - Lifetime DE69937735T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9810223.9A GB9810223D0 (en) 1998-05-13 1998-05-13 Selection system
GBGB9810228.8A GB9810228D0 (en) 1998-05-13 1998-05-13 Selection method
GB9810228 1998-05-13
GB9810223 1998-05-13
PCT/GB1999/001526 WO1999058655A2 (en) 1998-05-13 1999-05-13 Phage display selection system for folded proteins

Publications (2)

Publication Number Publication Date
DE69937735D1 true DE69937735D1 (de) 2008-01-24
DE69937735T2 DE69937735T2 (de) 2008-11-27

Family

ID=26313668

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69937735T Expired - Lifetime DE69937735T2 (de) 1998-05-13 1999-05-13 Phagen-display-selektionssystem für korrekt gefaltete proteine

Country Status (14)

Country Link
US (2) US7442159B1 (de)
EP (2) EP1950295A1 (de)
JP (2) JP4493846B2 (de)
AT (1) ATE380865T1 (de)
AU (1) AU762814B2 (de)
CA (1) CA2328422A1 (de)
CY (1) CY1107293T1 (de)
DE (1) DE69937735T2 (de)
DK (1) DK1078051T3 (de)
ES (1) ES2299244T3 (de)
GB (1) GB2361237A (de)
NO (1) NO329172B1 (de)
PT (1) PT1078051E (de)
WO (1) WO1999058655A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100890A2 (de) 1998-07-27 2001-05-23 Genentech, Inc. Verbesserung der transformationseffizienz in phagendisplay durch abänderung des hüllproteins
PT1144607E (pt) 1999-07-20 2009-04-22 Morphosys Ag Novos métodos para apresentar (poli)peptídeos/ proteínas em partículas bacteriofágicas através de ligações dissulfureto
AU3040101A (en) * 2000-02-03 2001-08-14 Domantis Limited Combinatorial protein domains
GB0019049D0 (en) * 2000-08-04 2000-09-27 Neutec Pharma Plc Combinatorial chemistry method
WO2002012277A2 (en) * 2000-08-07 2002-02-14 Domantis Limited Hybrid combinatorial proteins made from reshuffling of differently folded domains
DE10135039C1 (de) * 2001-07-18 2003-03-13 Nemod Immuntherapie Ag Verfahren zur Isolierung großer Varianzen spezifischer Moleküle für ein Zielmolekül aus Phagemid-Gen-Bibliotheken
WO2004101790A1 (en) 2003-05-14 2004-11-25 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
AU2006268780B2 (en) * 2005-07-08 2011-03-24 University Of Zurich Phage display using cotranslational translocation of fusion polypeptides
GB2428293A (en) * 2005-07-13 2007-01-24 Domantis Ltd Phage display libraries
EP1915617B1 (de) 2005-07-21 2011-09-14 Aebi Ltd. Verfahren und zusammensetzungen zur identifizierung eines peptids mit intermolekularer wechselwirkung mit einem interessierenden ziel
GB0515115D0 (en) 2005-07-22 2005-08-31 Isogenica Ltd Peptide characterisation
EP2032701B1 (de) * 2006-06-23 2013-11-27 Alethia Biotherapeutics Inc. An Krebs beteiligte Polynukleotide und Polypeptide
CA2688433A1 (en) 2007-06-06 2008-12-11 Domantis Limited Methods for selecting protease resistant polypeptides
CN101772574B (zh) 2007-08-21 2016-01-06 莫佛塞斯公司 改良的用于二硫键形成的方法
ES2614284T3 (es) 2007-11-30 2017-05-30 Glaxo Group Limited Construcciones de unión a antígenos
MX336869B (es) 2008-11-03 2016-02-04 Alethia Biotherapeutics Inc Anticuerpos que bloquean espicificamente la actividad biologica de un antigeno de tumor.
WO2010063818A2 (en) 2008-12-05 2010-06-10 Glaxo Group Limited Methods for selecting protease resistant polypeptides
EP2401297A1 (de) 2009-02-24 2012-01-04 Glaxo Group Limited Antigenbindende konstrukte
WO2010097394A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Multivalent and/or multispecific rankl-binding constructs
CA2753287A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
US20130236467A1 (en) 2010-11-24 2013-09-12 Jeremy Griggs Multispecific antigen binding proteins targeting hgf
MX352373B (es) 2011-03-31 2017-11-22 Adc Therapeutics Sa Anticuerpos contra antigeno 1 asociado con riñon y sus fragmentos de union de antigeno.
BR112014001855A2 (pt) 2011-07-27 2017-02-21 Glaxo Group Ltd construto e proteína aglutinantes ao antígeno, dímero, composição farmacêutica, sequência de polinucleotídeo, célula hospedeira e, método para produção do construto
AU2012327806B2 (en) 2011-10-27 2018-07-19 The Governors Of The University Of Alberta Device and method for bacterial culture and assay
CN111298119A (zh) 2012-01-09 2020-06-19 Adc治疗股份有限公司 用于通过使用肾相关抗原1（kaag1）的抑制剂来治疗三阴性乳癌和基底样乳癌的方法
CN106163556B (zh) 2013-09-25 2024-04-09 西托姆克斯治疗公司 基质金属蛋白酶底物和其它可切割部分及其使用方法
NZ722401A (en) 2014-01-31 2023-06-30 Cytomx Therapeutics Inc Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
EP3218479A1 (de) * 2014-11-11 2017-09-20 Nanocore ApS Verfahren zur identifizierung von molekülen mit gewünschten eigenschaften
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
SG11201706840WA (en) * 2015-03-31 2017-09-28 Vhsquared Ltd Peptide construct having a protease-cleavable linker
WO2020254644A1 (en) * 2019-06-21 2020-12-24 Boehringer Ingelheim International Gmbh Novel mechanism to control rna virus replication and gene expression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO1990005144A1 (en) 1988-11-11 1990-05-17 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
JP4146512B2 (ja) * 1991-03-01 2008-09-10 ダイアックス コープ． 小型タンパク質
DE4122599C2 (de) * 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
ES2227512T3 (es) 1991-12-02 2005-04-01 Medical Research Council Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.

Also Published As

Publication number Publication date
US20090203542A1 (en) 2009-08-13
CY1107293T1 (el) 2012-11-21
ES2299244T3 (es) 2008-05-16
ATE380865T1 (de) 2007-12-15
EP1078051A2 (de) 2001-02-28
JP2002514413A (ja) 2002-05-21
US7442159B1 (en) 2008-10-28
EP1078051B1 (de) 2007-12-12
GB2361237A (en) 2001-10-17
GB0026143D0 (en) 2000-12-13
JP5161865B2 (ja) 2013-03-13
US8680018B2 (en) 2014-03-25
JP2010148507A (ja) 2010-07-08
JP4493846B2 (ja) 2010-06-30
EP1950295A1 (de) 2008-07-30
NO20005628D0 (no) 2000-11-08
WO1999058655A2 (en) 1999-11-18
NO20005628L (no) 2001-01-12
CA2328422A1 (en) 1999-11-18
DK1078051T3 (da) 2008-04-07
PT1078051E (pt) 2008-03-17
WO1999058655A3 (en) 2000-01-27
NO329172B1 (no) 2010-09-06
DE69937735T2 (de) 2008-11-27
AU3941399A (en) 1999-11-29
AU762814B2 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
DE69937735D1 (de) Phagen-display-selektionssystem für korrekt gefaltete proteine
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
EP1712623A3 (de) Selektion von Proteinen unter Verwendung von RNA-protein-fusionen
DE69933216D1 (de) Erythropoietin-analog-menschliches serum-albumin fusionsprotein
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
ATE198491T1 (de) System zur expression von heterologen antigenen als fusionsproteine
NO20076467L (no) Fusjonsproteiner som omfatter HIV-1 Tat- og/eller Nef-proteiner
CA2245006A1 (en) Protein expression system
AR009436A1 (es) UNA PROTEíNA DE FUSIoN FC-OB, UNA SECUENCIA DE ÁCIDO NUCLEICO QUE LA CODIFICA, UN VECTOR, PROCEDIMIENTO DE PREPARACIoN, COMPOSICIONES FARMACÉUTICAS Y USOS.
DK1200479T3 (da) Multiple cytokin-antistof-komplekser
CY1111006T1 (el) Εκριμματαση ασθενειας alzheimer
DE60024659D1 (de) Vektoren und verfahren für rekombinante proteinexpression
WO2002022662A3 (en) Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor
IS6678A (is) Hvarfefni og prófanir fyrir ß-sekretasavirkni
DE69531235D1 (de) Säugetier - Expressionssysteme für Hüllenprotingene des Hepatitit - C - Virus
DK0977873T3 (da) Fremgangsmåde til spaltning af fusionsproteiner
WO1999003993A3 (en) Suppressors of cytokine signaling; related reagents
DE68923006D1 (de) Fusionsproteine der untereinheit b von choleratoxin und eines heterologen antigens und dafür kodierende rekombinante nukleinsäure.
WO2003020005A3 (en) Lp mammalian proteins; related reagents
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
DE69838324D1 (de) Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür
WO2000031127A3 (en) Protein fragments for use in protein targeting
DE69534178D1 (en) S?ugetier thymokingene
AU8405798A (en) A swine hepatitis e virus and uses thereof
WO2002074906A3 (en) Lp mammalian proteins; related reagents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition